Xiaozhi Xi

834 total citations
20 papers, 662 citations indexed

About

Xiaozhi Xi is a scholar working on Molecular Biology, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaozhi Xi has authored 20 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaozhi Xi's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Ginseng Biological Effects and Applications (3 papers) and Polysaccharides and Plant Cell Walls (3 papers). Xiaozhi Xi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Ginseng Biological Effects and Applications (3 papers) and Polysaccharides and Plant Cell Walls (3 papers). Xiaozhi Xi collaborates with scholars based in China and United States. Xiaozhi Xi's co-authors include Fangxue Xu, Chunchao Han, Mengmeng Zheng, Xiaowei Cui, Hui Cao, Yujuan Li, Hong Guo, Shiyuan Wang, Xuelan Zhang and Yujuan Li and has published in prestigious journals such as Frontiers in Immunology, Molecules and International Journal of Biological Macromolecules.

In The Last Decade

Xiaozhi Xi

19 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhi Xi China 12 332 200 116 111 92 20 662
Xiaowei Cui China 12 377 1.1× 253 1.3× 130 1.1× 119 1.1× 149 1.6× 29 788
Hui Ni China 17 317 1.0× 211 1.1× 152 1.3× 137 1.2× 68 0.7× 60 765
Zhongmei He China 15 376 1.1× 188 0.9× 96 0.8× 75 0.7× 135 1.5× 49 680
Mengmeng Zheng China 14 434 1.3× 237 1.2× 123 1.1× 177 1.6× 179 1.9× 31 851
Hee Ju Lee South Korea 18 441 1.3× 193 1.0× 86 0.7× 99 0.9× 67 0.7× 48 851
Deling Wu China 13 292 0.9× 275 1.4× 104 0.9× 71 0.6× 138 1.5× 73 651
Mei-Bian Hu China 15 318 1.0× 257 1.3× 76 0.7× 127 1.1× 91 1.0× 30 744
Wei-Zhe Liang Taiwan 16 275 0.8× 126 0.6× 88 0.8× 67 0.6× 59 0.6× 55 628
Linhong Fan China 13 318 1.0× 151 0.8× 78 0.7× 109 1.0× 69 0.8× 29 681
Eun‐Hwa Sohn South Korea 16 411 1.2× 143 0.7× 78 0.7× 110 1.0× 77 0.8× 45 774

Countries citing papers authored by Xiaozhi Xi

Since Specialization
Citations

This map shows the geographic impact of Xiaozhi Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhi Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhi Xi more than expected).

Fields of papers citing papers by Xiaozhi Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhi Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhi Xi. The network helps show where Xiaozhi Xi may publish in the future.

Co-authorship network of co-authors of Xiaozhi Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhi Xi. A scholar is included among the top collaborators of Xiaozhi Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhi Xi. Xiaozhi Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xi, Xiaozhi, et al.. (2025). Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs. Biomarker Research. 13(1). 41–41. 5 indexed citations
2.
Xi, Xiaozhi, et al.. (2025). Challenges and opportunities in single-domain antibody-based tumor immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(2). 189284–189284.
3.
Xi, Xiaozhi, Yanqing Wang, Jin Chen, et al.. (2024). A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy. Acta Pharmaceutica Sinica B. 14(11). 4806–4818. 13 indexed citations
4.
Xi, Xiaozhi, et al.. (2023). A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization. Frontiers in Immunology. 14. 1062656–1062656. 11 indexed citations
5.
Wang, Ruihong, Lin Liu, Xiaozhi Xi, et al.. (2023). Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA. Artificial Cells Nanomedicine and Biotechnology. 51(1). 509–519. 7 indexed citations
6.
Xi, Xiaozhi, et al.. (2019). Notoginsenoside R1: A systematic review of its pharmacological properties.. PubMed. 74(11). 641–647. 27 indexed citations
7.
Cao, Hui, Shiyuan Wang, Xiaowei Cui, et al.. (2019). Taking Ingredients as an Entry Point to Explore the Relationship between the Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Agaricomycetes), and Diabetes Mellitus (Review). International journal of medicinal mushrooms. 21(5). 493–502. 3 indexed citations
8.
Xu, Fangxue, Yujuan Li, Mengmeng Zheng, et al.. (2018). Structure Properties, Acquisition Protocols, and Biological Activities of Oleuropein Aglycone. Frontiers in Chemistry. 6. 239–239. 30 indexed citations
9.
Li, Yujuan, Fangxue Xu, Mengmeng Zheng, et al.. (2018). Maca polysaccharides: Extraction optimization, structural features and anti-fatigue activities. International Journal of Biological Macromolecules. 115. 618–624. 43 indexed citations
10.
Li, Yujuan, Fangxue Xu, Mengmeng Zheng, et al.. (2018). Maca polysaccharides: A review of compositions, isolation, therapeutics and prospects. International Journal of Biological Macromolecules. 111. 894–902. 54 indexed citations
11.
Xu, Fangxue, Shiyuan Wang, Yujuan Li, et al.. (2018). Yield enhancement strategies of rare pharmaceutical metabolites from endophytes. Biotechnology Letters. 40(5). 797–807. 24 indexed citations
12.
Xu, Fangxue, Chunchao Han, Yujuan Li, et al.. (2018). The Chemical Constituents and Pharmacological Actions of Silybum Marianum. Current Nutrition & Food Science. 15(5). 430–440. 8 indexed citations
13.
Li, Yujuan, Shiyuan Wang, Mengmeng Zheng, et al.. (2018). Maca Cosmetics: A Review on Constituents, Therapeutics and Advantages. Journal of Oleo Science. 67(7). 789–800. 4 indexed citations
14.
Xi, Xiaozhi, Hong Guo, Xiaowei Cui, et al.. (2018). Anti-exercise-fatigue and promotion of sexual interest activity of total flavonoids from wasps drone-pupae in male mice. Biomedicine & Pharmacotherapy. 107. 254–261. 13 indexed citations
15.
Cui, Xiaowei, Shiyuan Wang, Hui Cao, et al.. (2018). A Review: The Bioactivities and Pharmacological Applications of Polygonatum sibiricum polysaccharides. Molecules. 23(5). 1170–1170. 200 indexed citations
16.
Zhang, Qiang, Fangxue Xu, Yujuan Li, et al.. (2018). Silybum marianum seeds oil attenuates CCl4-induced hepatic fibrosis via regulation of inflammatory response and oxidative stress. Current Nutrition & Food Science. 14(3). 197–203. 4 indexed citations
17.
Xi, Xiaozhi, Jia Li, Yujuan Li, et al.. (2018). The Potential of Using Bee Pollen in Cosmetics: a Review. Journal of Oleo Science. 67(9). 1071–1082. 24 indexed citations
18.
Zheng, Mengmeng, Yujuan Li, Fangxue Xu, et al.. (2018). Ginsenosides: A Potential Neuroprotective Agent. BioMed Research International. 2018. 1–11. 99 indexed citations
19.
Zheng, Mengmeng, Fangxue Xu, Yujuan Li, et al.. (2017). Study on Transformation of Ginsenosides in Different Methods. BioMed Research International. 2017. 1–10. 80 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaowei Cui Breakdown of academic impact, for papers by Hui Ni Breakdown of academic impact, for papers by Zhongmei He Breakdown of academic impact, for papers by Mengmeng Zheng Breakdown of academic impact, for papers by Hee Ju Lee Breakdown of academic impact, for papers by Deling Wu Breakdown of academic impact, for papers by Mei-Bian Hu Breakdown of academic impact, for papers by Wei-Zhe Liang Breakdown of academic impact, for papers by Linhong Fan Breakdown of academic impact, for papers by Eun‐Hwa Sohn
Rankless by CCL
2026